Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 18
216
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Anti-infective potential of caffeic acid and epicatechin 3-gallate isolated from methanol extract of Euphorbia hirta (L.) against Pseudomonas aeruginosa

, &
Pages 1766-1769 | Received 18 Aug 2014, Accepted 11 Dec 2014, Published online: 09 Jan 2015
 

Abstract

Euphorbia hirta (L.) plant is traditionally used in Malaysia for the treatment of gastrointestinal, bronchial and respiratory ailments caused by nosocomial infectious agents. Bioactivity-guided fractionation of the methanol extract of the aerial parts of E. hirta and analysis using high-performance liquid chromatography have led to the isolation of two antibacterial compounds. These compounds were identified as caffeic acid (CA) and (–)-epicatechin 3-gallate (ECG) based on spectroscopic analyses and comparison with previously published data. Using broth microdilution method, both ECG and CA had demonstrated significant minimum inhibitory concentration of 15.6  and 31.3 μg/mL respectively, against Pseudomonas aeruginosa. Time-kill assessment of ECG and CA displayed bactericidal effect on P. aeruginosa cells.

Funding

This project was funded by the E-Science Fund [305/PFARMASI/613223], the Ministry of Science, Technology and Innovation (MOSTI) and the Short-Term Research Grant [304/PFARMASI/6312024], Universiti Sains Malaysia. The first author acknowledges MyBrain15 (Ministry of Education, Malaysia) for providing scholarship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.